The Anti-Melanoma Activity of Dinaciclib, a Cyclin-Dependent Kinase Inhibitor, Is Dependent on p53 Signaling
Brijal Desai(The Wistar Institute), Meenhard Herlyn(The Wistar Institute)
Cited by 63
Related Papers
A Tumorigenic Subpopulation with Stem Cell Properties in Melanomas
|Cancer Research|2005|1.3k
Human Melanoma Progression in Skin Reconstructs
|American Journal Of Pathology|2000|236
Low-Level Monocyte Chemoattractant Protein-1 Stimulation of Monocytes Leads to Tumor Formation in Nontumorigenic Melanoma Cells
|The Journal of Immunology|2001|231
The Essential Role of Fibroblasts in Esophageal Squamous Cell Carcinoma–Induced Angiogenesis
|Gastroenterology|2008|132
Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels
|British Journal of Cancer|2007|105